Routine clinical use of alemtuzumab in patients with heavily pretreated B-cell chronic lymphocytic leukemia: a nation-wide retrospective study in Austria.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples